You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The ABCs of Skin Care for Wound Care Clinicians: Dermatitis and Eczema

Woo, Kevin Y. RN, MSc, PhD, ACNP, GNC(C), FAPWCA; Sibbald, R. Gary BSc, MD, MEd, FRCPC (Med, Derm), ABIM DABD, FAPWCA

Advances in Skin & Wound Care:
doi: 10.1097/01.ASW.0000350837.17691.7f
Features: Clinical Management Extra
Abstract

PURPOSE: To provide the wound care practitioner with an overview of the nature and treatment of dermatitis.

TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care.

OBJECTIVES: After reading this article and taking this test, the reader should be able to:

1. Describe the pathophysiology of dermatitis.

2. Discuss the characteristics that help to differentiate common types of dermatitis.

3. Identify appropriate treatment strategies for dermatitis.

In Brief

In this continuing education activity, the authors discuss the different types of dermatitis and eczema treatments, and provide concrete strategies and basic information for busy wound care clinicians to integrate into practice.

Author Information

Kevin Y. Woo, RN, MSc, PhD, ACNP, GNC(C), FAPWCA • Clinical Scientist/Wound Care Specialist • Wound Healing Clinic • The New Women's College Hospital • Toronto, Ontario, Canada

R. Gary Sibbald, BSc, MD, MEd, FRCPC (Med Derm), MACP, FAAD, FAPWCA • Professor of Public Health Sciences and Medicine • University of Toronto • Toronto • Director • Wound Healing Clinic • The New Women's College Hospital • Toronto • President • World Union of Wound Healing Societies • Clinic Associate Editor • Advances in Skin & Wound Care • Ambler, PA

Dr Woo has disclosed that he is/was a recipient of grant/research funding from the Canadian Association of Wound Care; is/was a consultant/advisor to Coloplast, Mölnlycke, KCI, Merck, and the Registered Nurses of Ontario Association; and is/was a member of the speaker's bureau for Johnson & Johnson, Coloplast, and Mölnlycke. Dr Sibbald has disclosed that he is/was a recipient of grant/research funding from Coloplast, Smith & Nephew, 3M, KCI, Mölnlycke, Covidien, and Johnson & Johnson; is/was a consultant/advisor to Coloplast, Smith & Nephew, 3M, KCI, Mölnlycke, Covidien, and Johnson & Johnson; and is/was a member of the speaker's bureau for Coloplast, Smith & Nephew, 3M, KCI, Mölnlycke, Covidien, and Johnson & Johnson. All staff in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

Lippincott CME Institute, Inc, has identified and resolved all faculty and staff conflicts of interest regarding this educational activity.

© 2009 Lippincott Williams & Wilkins, Inc.